Posts Tagged ‘Op-ed’
Organizer explains why drug importation is dangerous and “doomed to fail”
This editorial, written by Earl D. Fowlkes Jr., appeared in the Washington Blade on December 4, 2020. Fowlkes is the president and CEO of the Center for Black Equity.
[...]Importation was “a waste of valuable federal and state tax dollars,” says fiscally-focused advocacy group
In this editorial, which was posted on December 2, 2020, Citizens Against Government Waste decries the expense and futility drug importation.
[...]There is no Way to Regulate the Quality of Drugs Imported by American Patients
This editorial by Brandon Macsata was published in The International Business Times on November 1, 2020. Macsata has been living with HIV since 2002, and serves as the CEO of the ADAP Advocacy Association, an organization that promotes the AIDS Drug Assistance Program and works to improve access to care.
[...]“Reducing costs requires more than all of this non–value-added activity,” Expert Says
In this October 23, 2020 editorial, which was published in the The American Journal of Managed Care, Michael Abrams explains why drug importation will not save patients money. Abrams is the co-founder and managing partner of Numerof & Associates.
[...]“…barriers will delay or prevent drug importation,” say regulatory experts
In this analysis, which was published in Lexology on October 13, 2020, three global regulatory experts examine barriers to drug importation.
[...]US Attorney for Arizona Calls Illicit Fentanyl “The Most Dangerous Drug We Have Confronted as a Nation”
In the first seven months of 2020, the Arizona Department of Health Services reported over 2,700 newly suspected opioid overdose deaths in Arizona. What makes this figure more startling is that there were just over 3,800 suspected opioid deaths in the preceding 30 months. The problem is escalating, and rapidly.
[...]Newspaper Editorial Board Says Canadian Drug Importation Will Have Limited Impact
The editorial board of the Florida Times-Union published an op-ed that states that Canadian drug importation will have a limited impact, and is a sign of a broken system, not a solution to one…
[...]“These drugs would go through additional shipping, inspection and repackaging. Why would they be cheaper?”
In this editorial, which was published in WBUR’s Cognoscenti on September 2, 2020, writer Sarah Ruth Bates explains why Canadian drug importation is too expensive and elaborate a solution to be effective.
[...]Louisiana AG Warns About Counterfeit Pills On College Campuses
In this editorial, Louisiana Attorney General Jeff Landry warns parents and students about the dangers posed by counterfeit pills being sold on college campuses.
[...]Canadian patient advocate urges American friends to reject the “empty promises” of importation
In this August 14, 2020 editorial, Best Medicines Coalition chair John Adams explains why Canadian importation will not lower U.S. medicine prices—and why the “concept of cheap drugs from Canada has never been anything more than a political hallucination.”
[...]